The Dolon Institute aspires to contribute to the policy conversations around patient access and promoting innovation in rare and severe diseases. Our work is grounded in the fundamentals of orphan medicine economics and experience engaging with stakeholders around the launch of orphan medicines. We seek to develop analyses and evidence-led insights disseminated through peer-reviewed publications, white papers and external events.
Introducing the Dolon Institute
February 2023
Dolon is pleased to announce the launch of the Dolon Institute, which aspires to contribute to the policy discussion that surrounds the development and availability of innovative medicines for rare and severe diseases globally. We hope to do our part…
Read more…Explore past Dolon publications here